116 related articles for article (PubMed ID: 2530379)
1. Immunopharmacological studies on TBX, a new antiallergic drug (4). Effects on type II to IV allergic reactions and immunological functions in animal models.
Yanagihara Y; Kasai H; Kawashima T; Ninomiya K
Jpn J Pharmacol; 1989 Sep; 51(1):93-100. PubMed ID: 2530379
[TBL] [Abstract][Full Text] [Related]
2. Immunopharmacological actions of the new antiallergic drug butyl 3'-(1H-tetrazol-5-yl)oxanilate. 1st communication: effects on type I to type IV allergic reactions in animal models.
Yanagihara Y; Abe T; Edanami K; Agata M; Kuroda T; Shida T
Arzneimittelforschung; 1988 Jan; 38(1):70-4. PubMed ID: 2966629
[TBL] [Abstract][Full Text] [Related]
3. Immunopharmacological studies on TBX, a new antiallergic drug (1). Inhibitory effects on passive cutaneous anaphylaxis in rats and guinea pigs.
Yanagihara Y; Kasai H; Kawashima T; Shida T
Jpn J Pharmacol; 1988 Sep; 48(1):91-101. PubMed ID: 2462074
[TBL] [Abstract][Full Text] [Related]
4. Immunopharmacological studies on TBX, a new antiallergic drug (3). Inhibitory effects on histamine release from lung fragments and bronchoconstriction in guinea pigs.
Yanagihara Y; Kasai H; Matsui S; Ninomiya K
Jpn J Pharmacol; 1989 Sep; 51(1):83-92. PubMed ID: 2478743
[TBL] [Abstract][Full Text] [Related]
5. [[Effect of traxanox sodium on type I-IV allergic reactions. Studies on anti-allergic agents VII].
Terasawa M; Goto K; Maruyama Y
Nihon Yakurigaku Zasshi; 1982 Dec; 80(6):417-27. PubMed ID: 6219052
[TBL] [Abstract][Full Text] [Related]
6. [Effect of KC-404 on allergic reactions types I-IV].
Nishino K; Hara S; Irikura T
Nihon Yakurigaku Zasshi; 1984 Apr; 83(4):291-9. PubMed ID: 6235160
[TBL] [Abstract][Full Text] [Related]
7. [Effects of YM-13650 on type I to type IV allergic reactions and immune responses in animals].
Yamada T; Tomioka K; Mase T; Murase K
Nihon Yakurigaku Zasshi; 1991 Feb; 97(2):75-84. PubMed ID: 1829062
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of epinastine on the type II-IV allergic reactions in mice, rats and guinea pigs.
Kamei C; Izushi K; Adachi Y; Shimazawa M; Tasaka K
Arzneimittelforschung; 1991 Nov; 41(11):1150-3. PubMed ID: 1687348
[TBL] [Abstract][Full Text] [Related]
9. Immunopharmacological studies on TBX, a new antiallergic drug (2). Inhibitory effects on histamine release from peritoneal mast cells and lung fragments of rats.
Yanagihara Y; Kasai H; Shida T
Jpn J Pharmacol; 1988 Sep; 48(1):103-12. PubMed ID: 2462073
[TBL] [Abstract][Full Text] [Related]
10. [Effects of MY-5116 on experimental animal models of type I-type IV allergic reactions and the formation of IgE antibody].
Takahashi K; Endoh K; Yamada N; Kadowaki S; Arai Y; Sugasawa K
Nihon Yakurigaku Zasshi; 1986 Sep; 88(3):245-54. PubMed ID: 2947841
[TBL] [Abstract][Full Text] [Related]
11. Effects of FR50948, a new orally active antiallergic agent, in experimental allergic models.
Hiroi J; Ohara K; Kobayashi K; Fujitsu T; Fujii T; Motoyama Y; Mori J; Shibayama F
Jpn J Pharmacol; 1988 Apr; 46(4):337-48. PubMed ID: 2457128
[TBL] [Abstract][Full Text] [Related]
12. Anti-allergic effects of ketanserin on animal models of allergic reactions.
Nagai H; Suda H; Kitagaki K; Goto S; Miura T; Koda A
Arch Int Pharmacodyn Ther; 1990; 307():172-82. PubMed ID: 1710442
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological properties of YM-11124, a selective immunosuppressive agent for cell-mediated immunity.
Tomioka K; Yamada T; Mase T; Murase K
Pharmacology; 1989; 39(1):28-38. PubMed ID: 2531424
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacological studies on oxatomide (KW-4354): (2) Effect on the experimental models of the type 1-type 4 allergic reactions].
Ohmori K; Ishii H; Hirayama T; Shuto K; Nakamizo N
Nihon Yakurigaku Zasshi; 1982 Sep; 80(3):261-70. PubMed ID: 6130033
[TBL] [Abstract][Full Text] [Related]
15. Effect of 6-ethyl-3-(1H-tetrazol-5-yl)chromone (AA-344) on the immediate and delayed hypersensitivity reactions.
Kuriki H; Saijo T; Ashida Y; Maki Y
Jpn J Pharmacol; 1979 Oct; 29(5):733-44. PubMed ID: 161338
[TBL] [Abstract][Full Text] [Related]
16. Effects of DS-4574, a new orally active antiallergic agent, in experimental allergic and inflammatory models.
Aibara S; Mori M; Iwamoto T; Tsubokawa M; Takamori H; Tsukada W
Jpn J Pharmacol; 1993 Apr; 61(4):267-76. PubMed ID: 8320873
[TBL] [Abstract][Full Text] [Related]
17. Immunopharmacological studies of sodium copper chlorphyllin (SCC).
Nagai H; Nishiyori T; Daikoku M; Koda A
Jpn J Pharmacol; 1983 Aug; 33(4):819-28. PubMed ID: 6195383
[TBL] [Abstract][Full Text] [Related]
18. Immunopharmacological studies of the aqueous extract of Cinnamomum cassia (CCAq). I. Anti-allergic action.
Nagai H; Shimazawa T; Matsuura N; Koda A
Jpn J Pharmacol; 1982 Oct; 32(5):813-22. PubMed ID: 6184511
[TBL] [Abstract][Full Text] [Related]
19. [Anti-allergic effects of (E)-3-[p-(1H-imidazol-1-ylmethyl)phenyl]-2-propenoic acid (OKY-046), a specific thromboxane (TX) A2 synthetase inhibitor: effect of OKY-046 on II-IV type allergic reactions].
Kikuchi S; Takehana Y; Hamano S; Ichikawa K; Komatsu H; Okegawa T; Ikeda S
Nihon Yakurigaku Zasshi; 1990 Mar; 95(3):131-7. PubMed ID: 2141317
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological studies of N-(2-mercapto-2-methylpropanoyl)-L-cysteine (SA96) (3). Effects of SA96 on experimental allergic reactions.
Nakata K; Suda H; Yamauchi H; Iso T
Jpn J Pharmacol; 1985 Jan; 37(1):83-90. PubMed ID: 3157817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
